Pegylated liposomal doxorubicin (Duomeisu®) monotherapy in patients with HER2-negative metastatic breast cancer heavily pretreated with anthracycline and taxanes: a single-arm, phase II study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Pegylated liposomal doxorubicin (Duomeisu®) monotherapy in patients with HER2-negative metastatic breast cancer heavily pretreated with anthracycline and taxanes: a single-arm, phase II study ; volume:199 ; number:1 ; day:6 ; month:3 ; year:2023 ; pages:67-79 ; date:5.2023
Breast cancer research and treatment ; 199, Heft 1 (6.3.2023), 67-79, 5.2023
- Urheber
-
Jiang, Hanfang
Li, Huiping
Song, Guohong
Di, Lijun
Shao, Bin
Yan, Ying
Liu, Xiaoran
Chen, Yifei
Zhang, Ruyan
Ran, Ran
Liu, Yaxin
Gui, Xinyu
Wang, Nan
Wang, Huan
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10549-023-06894-3
- URN
-
urn:nbn:de:101:1-2023090510390690962391
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jiang, Hanfang
- Li, Huiping
- Song, Guohong
- Di, Lijun
- Shao, Bin
- Yan, Ying
- Liu, Xiaoran
- Chen, Yifei
- Zhang, Ruyan
- Ran, Ran
- Liu, Yaxin
- Gui, Xinyu
- Wang, Nan
- Wang, Huan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Lenalidomide in heavily pretreated refractory diffuse large B-cell lymphoma: a case report
Therapeutic options in heavily pretreated HIV-1 patients based on the genotypic resistance patterns
BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas
Switch from enfuvirtide (ENF) to raltegravir (RAL): a simplification option for heavily pretreated HIV patients (pts)
Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma
Real-world data of HER2-negative early breast cancer patients treated with anthracycline and/or taxane regimens in Japan
An uncommon response to metronomic therapy in a heavily pretreated patient with metastatic carcinosarcoma: a case report
A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer
Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients
Megestrol Acetate for Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer: An Old Answer for a New Problem
Venetoclax plus cyclophosphamide and topotecan in heavily pre-treated relapsed metastatic neuroblastoma: a single center case series
Penpulimab, an anti-PD-1 antibody, for heavily pretreated metastatic nasopharyngeal carcinoma: a single-arm phase II study
Lenalidomide in heavily pretreated refractory diffuse large B-cell lymphoma: a case report
Therapeutic options in heavily pretreated HIV-1 patients based on the genotypic resistance patterns
BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas
Switch from enfuvirtide (ENF) to raltegravir (RAL): a simplification option for heavily pretreated HIV patients (pts)
Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma
Real-world data of HER2-negative early breast cancer patients treated with anthracycline and/or taxane regimens in Japan
An uncommon response to metronomic therapy in a heavily pretreated patient with metastatic carcinosarcoma: a case report
A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer
Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients
Megestrol Acetate for Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer: An Old Answer for a New Problem
Venetoclax plus cyclophosphamide and topotecan in heavily pre-treated relapsed metastatic neuroblastoma: a single center case series
Penpulimab, an anti-PD-1 antibody, for heavily pretreated metastatic nasopharyngeal carcinoma: a single-arm phase II study
Lenalidomide in heavily pretreated refractory diffuse large B-cell lymphoma: a case report
Therapeutic options in heavily pretreated HIV-1 patients based on the genotypic resistance patterns
BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas
Switch from enfuvirtide (ENF) to raltegravir (RAL): a simplification option for heavily pretreated HIV patients (pts)
Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma
Real-world data of HER2-negative early breast cancer patients treated with anthracycline and/or taxane regimens in Japan
An uncommon response to metronomic therapy in a heavily pretreated patient with metastatic carcinosarcoma: a case report
A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer
Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients
Megestrol Acetate for Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer: An Old Answer for a New Problem
Venetoclax plus cyclophosphamide and topotecan in heavily pre-treated relapsed metastatic neuroblastoma: a single center case series